Venetoclax with high‐dose methotrexate and rituximab seem effective and well‐tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case report
Journal article published in 2020 by
Guillaume Beziat 
,
Martin Gauthier ,
Caroline Protin,
Lucie Oberic,
Fleur Lerebours,
Jasmine Carlier,
Loïc Ysebaert
,
Martin Gauthier ,
Caroline Protin,
Lucie Oberic,
Fleur Lerebours,
Jasmine Carlier,
Loïc Ysebaert
This paper is made freely available by the publisher.
Full text: Download
Data provided by 